Results 231 to 240 of about 3,564,139 (354)

Severe acute respiratory syndrome coronavirus 2 transaminase elevation likely of non‐hepatic origin, with protection from older age and vaccination

open access: yesJPGN Reports, EarlyView.
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has known liver tropism. Multiple reports and studies demonstrated liver injury early in the pandemic. This retrospective cross‐sectional comparison evaluates predictors of transaminase elevation during acute SARS‐CoV2 infection, with particular interest in evaluating whether ...
Antonia F. Ovale   +6 more
wiley   +1 more source

The Immune Responses against Coronavirus Infections: Friend or Foe? [PDF]

open access: yesInt Arch Allergy Immunol, 2021
Vafaeinezhad A, Atashzar MR, Baharlou R.
europepmc   +1 more source

Colorectal Cancer Surgery at a Regional Cold Site Centre During the SARS‐CoV‐2 Pandemic: A Comparison With Prepandemic Practices

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Introduction Stockholm, Sweden had among the highest excess mortality rates during the first wave of the SARS‐CoV‐2 pandemic. In March 2020, an entire hospital implemented an infection‐free cold site infrastructure and scaled up imperative mainly colorectal cancer surgery, for the Stockholm health care region.
Mattias Soop   +4 more
wiley   +1 more source

Endolysosome-targeted nanoparticle delivery of antiviral therapy for coronavirus infections. [PDF]

open access: yesLife Sci Alliance
Petcherski A   +14 more
europepmc   +1 more source

Diverse Cellular Tropisms and Immune Responses during Beta-Coronavirus Infections in Human Bronchial Epithelial Organoids

open access: yes, 2023
Choi YK   +11 more
europepmc   +1 more source

Entry of coronavirus into primate CNS following peripheral infection

open access: green, 1994
Gary F. Cabirac   +7 more
openalex   +1 more source

Complexity of Basal Cell Carcinoma Surgery Between 2017 and 2022: The Impact of the COVID‐19 Pandemic

open access: yesJEADV Clinical Practice, EarlyView.
Since the declaration of the COVID‐19 pandemic in Vienna, basal cell carcinoma surgeries decreased by 32.5%, with numbers still not reaching pre‐pandemic levels in 2022. Patients who have undergone surgery since 2020 tend to be older and present with more comorbidities. However, the complexity of surgeries has remained unchanged.
Helena Heinrich   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy